Mira Pharmaceuticals (MIRA) Cash from Operations (2022 - 2025)

Mira Pharmaceuticals has reported Cash from Operations for 4 years, with the latest figure at 1200000.0 in Q4 2025.

• Quarterly Cash from Operations rose 33.52% year-over-year to 1200000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 4700000.0 (up 15.48% YoY) and the FY2025 annual result came in at 4700000.0, up 15.48% from the prior year.
• Cash from Operations slipped to 1200000.0 in Q4 2025 per MIRA's latest filing, from 1100000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 660813.0 in Q2 2023 and troughed at 1842111.0 in Q3 2024.
• A 4-year average of 1220245.36 and a median of 1087653.0 in 2023 frame the typical range for Cash from Operations.
• The sharpest annual moves came in 2024 and 2025: Cash from Operations plunged 74.4% in 2024, then surged 40.29% in 2025.
• Over 4 years, Cash from Operations stood at 975436.0 in 2022, then slipped by 6.11% to 1035015.0 in 2023, then slumped by 74.4% to 1805030.0 in 2024, then surged by 33.52% to 1200000.0 in 2025.
• According to Business Quant data, Cash from Operations over the past three periods registered 1200000.0, 1100000.0, and 769973.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.